EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57

Abstract

NATIONWIDE POPULATION-BASED STUDY OF MEN WITH FIBROMYALGIA AND ASSOCIATE COMORBIDITIES IN TAIWAN

Hsin-Li Liu, RN, MSN, Horng-Mo Lee, Ph. D, Yueh-Chin Chung, Ph. D*

ABSTRACT

Background: We calculated the incidence rate of fibromyalgia (FM) and comorbidities because of the lack of previous studies based on the incidence data of FM in Taiwanese males. The study was a population-based retrospective cohort study. Methods: We analyzed the 2000–2009 claims data on outpatients for FM diagnosis (ICD-9-CM codes 729.1) from the National Health Insurance Research Database. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Results: Cases of FM in 100,603 males (44.77%) and 125,632 females (55.53%) were studied, with a male to female ratio of 0.75–0.87. The annual incidences of men with FM from 2000 (20.57 per 1,000 people/year) to 2009 (18.62 per 1,000 people/year) and peaked in 2004 (25.40 per 1,000 people/year). Among the Taiwanese population, the incidence rate of men with FM was the highest data (115.21 per 1,000 people/year) than men from other countries. Comorbidities in men with FM include musculoskeletal pain conditions (36.10%), neuropathic pain conditions (14.64%), and respiratory tract infections (14.27%). The males of FM & non-FM related comorbidities showed significantly higher FM are of acute renal failure (OR 8.52, 95% CI, 1.05–69.47; p =0.045), and hydronephrosis (OR 2.59, 95% CI, 0.88–7.65; p =0.085). Conclusion: People with FM aged 40–64 years had a higher incidence and renal disease than the non- FM group. FM directly or indirectly interferes with or decreases the physical activity levels, emotional function and quality of life. Therefore, it is important to detect and treat FM early in order to promote physical activity and comorbidities control.

Keywords: fibromyalgia,men, comorbidities, nationwide population-based study.


[Full Text Article] [Download Certificate]

Citation

  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 April 2024 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: APRIL ISSUE PUBLISHED

    APRIL 2024 issue has been successfully launched on APRIL 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia